Who should not take Sermorelin?
Documented caution flags for Sermorelin include active malignancy and pituitary disorders. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Sermorelin is limited.
Documented caution flags for Sermorelin
- Active malignancy
- Pituitary disorders
- Pregnancy / nursing
Reported side effects to weigh
- Head-rush at injection
- Hunger pulse 30-60 min post-dose
- Mild flushing
References
- Sermorelin: a better approach to GH supplementation? — Walker RF, Clin Interv Aging, 2006
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency — Prakash A & Goa KL, BioDrugs, 1999
- Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone — Ogilvy-Stuart AL et al., Clinical Endocrinology (Oxford), 1997
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Sermorelin
Full Sermorelin breakdownSermorelin what it's used forSermorelin side effectsSermorelin how to take itSermorelin mistakes to avoidSermorelin half-lifeSermorelin how long to workSermorelin legal statusSermorelin how it workshgh vs sermorelintesamorelin vs sermorelincjc 1295 vs sermorelinAsk the AI Coach
Last updated 2026-06-15.